Legal 500
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • News & Developments
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • News & Developments
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Data Protection policies
  • Cookies Policy
  • Supplier Code of Conduct
  • Modern Slavery and Human Trafficking Statement
  • Contact Us
  • home
  • Market Intelligence
  • Search

4,681 results found

Use advanced search filters to refine your search

1 filter applied

Advanced search filters

Topics
Countries
Contributor
Content type
Show options
  • Article

    California Spotlight: Impact Of The Mid-Term Elections On The Life Sciences Industry

    As expected, Gavin Newsom was recently elected to be the next Governor of California.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    DOJ's Focus On Medicare Advantage Yields $100 Million FCA Settlement With Plan, Vendor, And CEO

    After a nearly decade-long whistleblower suit, Medicare Advantage (MA) Plan Independent Health Association and its subsidiary Independent Health Corporation (collectively, Independent Health), as well as diagnosis coding...
    United StatesFood, Drugs, Healthcare, Life Sciences
Arnold & Porter
Arnold & Porter
  • Article

    EMA Reflection Paper On Paediatric Extrapolation

    In July, we reported that the European Medicines Agency and the US Food and Drug Administration had announced a joint proposal to promote the use of innovative approaches to paediatric drug development.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    FDA Seeks Comments On Medical Device Cybersecurity Communications Framework Discussion Paper

    On October 19, 2020, the Food and Drug Administration's (FDA) Center for Devices and Radiological Health released a draft discussion paper titled...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    From "Red Flags" To False Claims: DOJ Intervenes In Opioid Suit Against Rite Aid

    On March 13, 2023, just a week after announcing the creation of the Opioid Epidemic Civil Litigation Task Force, the Department of Justice intervened in an FCA suit in the Northern District...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    Judge Orders Precision Lens And Co-Founder To Pay US$487 Million In Damages And Penalties Stemming From Kickback Verdict

    In February, a federal jury in Minnesota found that Precision Lens and its co-founder, Paul Ehlen (together, Defendants), violated the False Claims Act (FCA) by submitting over 64,500...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    Navigating Patient Needs Remotely: Addressing Challenges In Patient Access

    During the second webinar in our series on "Addressing Challenges and Mitigating Risks During the COVID-19 Pandemic and Beyond," our panel covered the following topics: ◾the effects of insurance loss / economic disruption...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    No "Cause" For Concern: Despite Supreme Court Setback, Trial Jury Vindicates SuperValu

    In June 2023, FCA practitioners around the country became familiar with U.S. ex rel. Schutte v. SuperValu Inc., when the Supreme Court issued its opinion in that case. As Qui Notes readers will recall...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    Pain Management Clinic Fined $1.19 Million For Alleged HIPAA Security Rule Violations

    On December 3, 2024, the U.S. Department of Health and Human Services Office for Civil Rights announced a $1.19 million civil monetary penalty against a Florida-based pain management clinic for alleged violations of the HIPAA Security Rule.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    Pressing Forward: Oversight Subcommittee Explores Lessons Learned At Pandemic Fraud Hearing

    On October 19, the House Ways and Means Oversight Subcommittee (Subcommittee on Oversight) held a hearing on "Investigating Pandemic Fraud: Preventing History from Repeating Itself."
    United StatesFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    The Eighth Circuit Teaches Relators: Don't Ask A Question Unless You Can Plead The Answer Under Rule 9(b)

    Earlier this summer, the Eighth Circuit was the latest circuit to weigh in on the growing split regarding what precisely a relator must plead to satisfy Rule 9(b)'s
    United StatesFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    Update On Clinical Trials Transparency In The EU

    Publication of clinical trial data and results continues to be a hot topic in the EU.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    With Big Third Quarter (And Even Bigger Beginning To Q4), DOJ Fast Approaching Total FCA Recoveries From FY2018

    As usual, the Q3 numbers were driven mainly by a handful of large recoveries—mostly from the pharmaceutical industry.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    BSA/AML Reform Under The NDAA

    On January 1, 2020, Congress voted to override the president's veto of the National Defense Authorization Act for Fiscal Year 2021 (NDAA), enacting the most significant overhaul of the...
    United StatesGovernment, Public Sector
    Arnold & Porter
    Arnold & Porter
  • Article

    DOJ Procurement Collusion Strike Force Earns Conviction

    On June 7, 2021, under the terms of a plea agreement, Judge Louise Flanagan of the US District Court for the Eastern District of North Carolina ordered Contech Engineered Solutions LLC (Contech) to pay...
    United StatesGovernment, Public Sector
    Arnold & Porter
    Arnold & Porter
  • Article

    Former Assistant To US Solicitor General Allon Kedem Joins Arnold & Porter's Appellate And Supreme Court Practice

    Mr. Elwood said: "Allon is one of the most talented Supreme Court advocates in the country.
    United StatesGovernment, Public Sector
    Arnold & Porter
    Arnold & Porter
  • Article

    Governor Newsom Signs Sweeping Climate Disclosure Laws And Calls For Amendments

    Over the weekend, Governor Newsom signed California's first in the nation greenhouse gas (GHG) emissions disclosure and climate-related financial risk reporting legislation...
    United StatesGovernment, Public Sector
    Arnold & Porter
    Arnold & Porter
  • Podcast

    How To Win On Policy In 2025: Don't Skip 2024 (Podcast)

    There's only six months until Election Day, but we can't write off 2024 as just another "election year." Our policy analysts with decades of Hill experience discuss how the seeds...
    United StatesGovernment, Public Sector
    Arnold & Porter
    Arnold & Porter
  • Article

    Our Predictions For 2024: False Claims Act Constitutionality

    In the latest episode of Bona Fide Needs, Pub K Managing Editor Bill Olver is joined by Arnold & Porter False Claims Act Investigations & Defense attorneys Christian Sheehan...
    United StatesGovernment, Public Sector
    Arnold & Porter
    Arnold & Porter
  • Article

    Reviewing The Tenure Of Justice Mary Jane Theis (Part 5 Of 6)

    This time, we've reached the home stretch in our review of Justice Theis' tenure. In this post, we're reviewing the areas of law in which she's written civil majority and civil dissents.
    United StatesGovernment, Public Sector
    Arnold & Porter
    Arnold & Porter
  • Showing 821–840 of 4681 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics